Patents by Inventor Rafaël Mols

Rafaël Mols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiple-tumor aberrant growth genes
    Publication number: 20110318834
    Abstract: The invention relates to the multi-tumor aberrant growth gene having the nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof. The gene and its derivatives may be used in various diagnostic and therapeutic applications.
    Type: Application
    Filed: May 25, 2007
    Publication date: December 29, 2011
    Applicant: Vlaams Interuniversitair Instituut Voor
    Inventors: Jorn Bullerdiek, Willem Jan Marie Van de Ven, Henricus Franciscus Petrus Maria Schoenmakers, Rafael Mols
  • Multiple-tumor aberrant growth genes
    Publication number: 20030190285
    Abstract: The invention relates to the multi-tumor aberrant growth gene having the nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof. The gene and its derivatives may be used in various diagnostic and therapeutic applications.
    Type: Application
    Filed: January 28, 2003
    Publication date: October 9, 2003
    Inventors: Jorn Bullerdiek, Willem Jan Marie Van de Ven, Henricus Franciscus Petrus Maria Schoenmakers, Rafael Mols
  • Multiple-tumor aberrant growth genes
    Patent number: 6544784
    Abstract: The present invention relates to the multi-tumor Aberrant Growth (MAG) gene having the nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions thereof. The gene and its derivatives may be used in various diagnostic and therapeutic applications.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: April 8, 2003
    Assignee: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW
    Inventors: Jörn Bullerdiek, Willem Jan Marie Van de Ven, Henricus Franciscus Petrus Maria Schoenmakers, Rafaël Mols